BBIO BridgeBio Pharma Inc

P/E --

Forward P/E --

Price/Sales 22.23

Beta 0.983

Div Yield --

Market Cap --

Company Analysis

Latest News

August 26, 2026

Farallon Capital Discloses New $695.5M Stake in BridgeBio Pharma

Farallon Capital Management has established a significant new position in BridgeBio Pharma (BBIO), a biopharmaceutical company focused on genetic conditions....